Watkins-Conti Products, Inc

Watkins-Conti Products, Inc is a women's pelvic health medical device company specializing in solutions for stress urinary incontinence management. The company's flagship product, Yōni.Fit, is a novel device for managing stress urinary incontinence that received FDA 510(k) clearance in August 2024 following a randomized controlled clinical trial conducted by urogynecologists at Stanford, NYU Langone, and Jefferson Health. The company is women-owned and based in Edmond, Oklahoma. Watkins-Conti develops and markets medical devices targeting the women's pelvic floor health market, with clinical validation from leading academic medical centers and endorsements from board-certified obstetrics and gynecology specialists.